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1. INTRODUCTION TO THE GUIDELINES 
 
1.1 The Aims of the North West Clinical Effectiveness Group 
 
The North West Clinical Effectiveness Group (NWCEG) for the Foot in Rheumatic Diseases 
was initiated by the North West Region Podiatry Heads of Service in 2003. Members of the 
group include podiatrists who currently work with patients with rheumatic diseases, a 
representative from service managers and an academic link with the University of Salford.  
The work of this group aims to contribute to the global aim of improving the care of patients 
with musculoskeletal and rheumatic diseases (Harris 2001) by supporting service 
development and the professional development of those podiatrists involved in the 
management of patients with rheumatic diseases through the following objectives: 
• To provide a support network for podiatrists in the NW region working within the field of 
rheumatology 
• To promote podiatry within the wider rheumatology community and as part of the 
multidisciplinary team 
• To review and revise these and other guidelines for the management of the foot in 
rheumatic disease as a framework for services 
• To review new evidence from research and disseminate information into practice. 
• To encourage clinical development in this field through increasing awareness amongst 
service commissioners and providers. 
• To identify the training and education needs of podiatrists to facilitate the development of 
specialist skills to maximise their clinical effectiveness and enhance patients’ experience. 
 
 
1.2 The First Edition of the NWCEG Guidelines (2004) 
 
One of the first activities of the group was to produce the initial guidelines for the Management 
of the Foot and Ankle in Rheumatic Diseases. 
The first edition of these guidelines was completed and disseminated in 2004 and have been 
used across the Northwest region to both instigate service provision and support service 
review. Further to this they have been adopted by various podiatry services as best practice 
guidelines all over the UK. 
The guidelines received national recognition as being the first in this area and received the 
support of the Podiatry Rheumatic Care Association (PRCA), and the NHS electronic library 
(NeLH). The NW CEG has also been actively involved in the development of the PRCA 
Standards of Care for People with Musculoskeletal Foot Health Problems (PRCA 2008) and 
as registered stakeholders, in the development of NICE guidance for the Management of 
Rheumatoid Arthritis in Adults (NICE 2009). 
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1.3 The Purpose of the Current Revised Guidelines 
 
The PRCA Standards of Care for People with Musculoskeletal Foot Health Problems are 
‘patient facing’ in respect of the service that patients can expect and in this context 
superseded this aspect of the original NW guidelines. Further to this, the NWCEG identified a 
need for standards to be defined for the specific foot health management of patients, 
particularly those with rheumatoid arthritis. To this end, the original guidelines have been 
revised and developed to be ‘practitioner facing’ with the objective of 'doing the right thing, to 
the right patient, in the right way, at the right time’ by rationalising and improving the quality of 
foot health management. Further to this, they now focus on the assessment and management 
of foot and ankle problems associated with rheumatoid arthritis. 
The aim of these revised guidelines is to provide all podiatrists who may be managing patients 
with RA with recommendations for the evidence based and best practice management of RA 
related foot and ankle problems.  
 
 
 
2. BACKGROUND TO RHEUMATOID ARTHRITIS  
 
2.1 Epidemiology and Clinical Features of RA 
Rheumatoid Arthritis (RA) is an auto-immune, systemic, inflammatory joint disease with a 
chronic, unpredictable and fluctuating course (Conaghan et al 1999). There are around 400,000 
adults in the UK with RA and approximately 20,000 new cases every year (Symmons et al 
2002). Up to 4 out of every 10 working people with RA lose their jobs within five years; three 
quarters of these are for reasons directly related to their condition (Young et al 2002). Barrett et 
al (2000) suggest 1 in 7 give up work within one year of diagnosis with health and related costs 
of between £0.8 and £1.3 billion.  
 
RA commonly affects the foot having diverse multidimensional implications including pain, 
changes in gait, deformity and restrictions in the choice of footwear (Bouysset et al 2006). The 
basic pathological changes in the rheumatoid foot result from synovitis coupled with mechanical 
stress (Spiegel & Spiegel 1982). These structural and functional changes often affect gait and 
mobility (Woodburn 2002, Turner et al 2006), impacting on the patient’s quality of life (Wickman 
et al 2004). The foot is often the first area of the body to be systematically afflicted by RA (Otter 
et al. 2004). 75% of patients with RA report foot pain within 4 years of diagnosis (Lohkamp et al 
2006), with the degree of disability progressing with the course of the disease. Shi et al (2000) 
states that virtually 100% of patients report foot problems within 10 years of disease onset.  
Specifically, the common manifestations of RA in the foot include hallux valgus, valgus heel 
deformity and lesser toe deformities. This foot deformity also predisposes to callus formation 
and in a number of patients, foot ulceration particularly in cases with poor tissue viability.  
Further to this, bacterial and fungal skin infections and nail pathologies are more prevalent in 
this patient group adding to the serious risk of ulceration and systemic infection. The risk of 
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opportunistic infections is increased if the patient’s medical management is with 
immunosuppressive drugs (Wilski 1993, Jones 1997). 
 
 
2.2 Recommendations for the Management of RA Foot Problems 
 
Woodburn and Helliwell (1997) report that the goals of foot care for patients with RA are to 
relieve pain, maintain function and improve quality of life using safe and cost-effective 
treatments, such as palliative foot care, prescribed foot orthoses and specialist footwear. Foot 
health needs for the patient with RA are varied. They range from simple foot care advice, 
palliative care for nails and skin and orthotic / specialist footwear provision through to 
management of ulceration and infection (Helliwell 2003, Korda and Balint 2004). 
Specific tools for measuring the impact of foot pathology on foot pain function and disability in 
patients with rheumatic diseases have been validated (Helliwell et al 2005 Garrow 2001, 
Budiman-Mak et al 1991, Platto et al 1991). These are now being used in clinical practice as 
well as in research. 
It is becoming increasingly recognised that management strategies for RA should be 
aggressive, comprising proactive management and prompt intervention (Luqmani et al, 2006: 
Emery et al, 2002). The Arthritis and Musculoskeletal Alliance (ARMA 2004) recommends that 
all patients with suspected RA should be seen by a specialist in rheumatology within 12 weeks 
to confirm diagnosis and enable prompt and effective treatment, and have access to a full 
multidisciplinary team (MDT) assessment and intervention early in the disease process, 
including foot health assessment. Further to this, Woolf et al (2007) suggest that management 
requires an integrated coordinated multidisciplinary, multi-professional approach, with care 
focussed upon the needs of the affected person, providing access to a combination of expertise 
and competencies.  
 
Given that podiatrists are considered the experts in the management of foot and ankle 
problems and recognised by NICE (2009) as primary provider of foot health services for this 
patient group, they should be an integrated part of the MDT. This view is supported by ARMA 
(2004), the British Society for Rheumatology (BSR) (Luqmani et al 2006) and the National 
Institute for Clinical Excellence (NICE 2009) who all strongly advocate the need for a dedicated 
and specialist podiatry service for the diagnosis, assessment and management of foot 
problems associated with RA along with periodic review.  
 
Patient organisations (Arthritis Research UK, Arthritis Care, and the National Rheumatoid 
Arthritis Society) also recommend that patients have access to specialist foot care and 
increasingly rheumatologists are requesting specialist foot care services for their patients 
(Williams 2001a).  
 
In this respect, podiatry care should be made available to all patients with rheumatoid arthritis 
and patients should understand the role of the podiatrist in helping them to effectively manage 
their foot health and how to seek help should they experience problems. Good communication 
between health professional and their patients’ is essential. People with RA should have the 
opportunity to make informed decisions about their care and treatment, in partnership with their 
Fig 2 
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health professionals (NICE 2009). Treatment and care should take into account peoples’ needs 
and preferences.  
 
 
 
 
3. PODIATRY SERVICE PROVISION 
 
 
3.1 Philosophy of Podiatry Services for People with RA 
 
The broad philosophy of podiatry management of people with RA is to relieve pain, maintain 
function and mobility, prevent or minimise deformity and reduce the risk of ulceration thereby 
maintaining or improving the individuals’ independence and overall quality of life. 
 
Podiatry services should provide a specific and dedicated service for the diagnosis, 
assessment and management of foot problems associated with RA that can be provided in a 
variety of settings, such as local clinics, hospital out-patient departments, and rheumatology 
departments (both outpatient and inpatient). However, it is acknowledge that some patients 
choose to access private podiatry care from HPC registered practitioners.   
 
 
 
3.2 Clinical Specialist Role 
 
 A podiatry team led by a dedicated podiatry clinical specialist in rheumatology is desirable. This 
specialist should provide specialist care directly to patients, provided advise for other members 
of the podiatry and multidisciplinary team (MDT) and facilitate the development of appropriate 
clinical skills in other members of the podiatry team  This clinical specialist should work within 
the rheumatology department (outpatients and inpatients) for at least part of their work 
schedule.  
 
The advantages of this are that the specialist podiatrist can: 
• Improve the profile of podiatry services within rheumatology 
• Provide timely interventions for acute problems using extended practices that 
historically have required referral to secondary care. 
• Provide timely referrals to appropriate members of the MDT. 
• Develop inter professional working practices. 
• Develop their role as advisor to the MDT 
 
 
 
3.3 Essential Requirements for a Podiatry Service 
 
Based on the national recommendations (NICE 2009 and ARMA 2004) the following are 
considered the essential requirements that a podiatry service is expected to provide for patients 
with RA: 
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- A team of podiatrists with knowledge of the foot health management of patients with RA 
and knowledge of the medical and rehabilitation management of the disease. 
 
- A system for prioritising referrals so that foot pathologies are managed in a timely way 
 
- The facilities for rapid assessment for patients should urgencies occur so that patients in 
acute pain or at risk of infection receive timely interventions. Patients who are being 
managed with biologic therapies should have immediate access to a specialist podiatrist 
if they present with foot ulceration or other infections affecting the foot. 
 
- Provision of the appropriate facilities / skills for baseline vascular and sensory 
assessment i.e. hand held Doppler ultrasound and 10g monofilament. It is known that 
patients with rheumatoid arthritis are more at risk than the general population for 
coronary heart disease (resulting in circulatory insufficiency to the lower limb), vasculitis 
and neuropathy. Baseline and annual assessments of the vascular and neurological 
status of patients will both identify and monitor any problems or changes (Kitas 2003). 
 
- Annual review and assessment of foot health in RA patients with identified foot problems 
(NICE 2009) 
 
- The skills to provide biomechanical assessment of foot structure and function 
 
- Provision of the appropriate facilities for biomechanical assessment of foot structure and 
function with either manufacturing or supplying foot orthoses. It is know that foot 
orthoses are a vital and effective intervention in rheumatoid arthritis (Woodburn et al 
2002(a), McSween 1999, Hodge et al 1999, Budiman-mak et al 1995) 
 
- Provision of specialist footwear or referral to an orthotist depending on local 
arrangements. It is known that many foot problems cannot be accommodated in normal 
retail footwear and the benefits of specialist prescription footwear are recognised 
(Chalmers et al 2000, Fransen and Edmonds 1997) 
 
- Individual patient education and care plans. Patients need information to enable them to 
make informed choices about their treatment. The information should be provided with 
professional support and guidance with the emphasis on behavioural change rather than 
just information giving (Reisema et al 2002). 
 
- A system of providing prompt and appropriate information to the referrers and other 
appropriate members of the multidisciplinary team. This is to facilitate good 
communication and collaboration between the podiatrist and the other members of the 
team so that care is timely and appropriate.. 
 
- Clinical documentation for recording of assessments, management plans, treatments 
and other interventions. In addition to the legal requirements for documentation of clinical 
treatments they can be used for purposes of audit 
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- An effective system of Continuing Professional Development, which includes 
o Annual Update Courses in Rheumatology 
o Multidisciplinary training  
  
 
3.4 ‘Gold Standard’ Requirements for a Podiatry Service 
 
This would include all the essential criteria plus the following desirable criteria 
 
- A team of podiatrists, led by the clinical specialist in the management of patients with 
RA. A designated clinical lead with advanced skills, experience and competencies would 
co-ordinate the service at a clinical level and be responsible for cascading new evidence 
based practice to other members of the podiatry team. They would act as clinical advisor 
for the team and be responsible for ensuring appropriate CPD in this area. 
 
- The facilities for providing telephone advice and rapid assessment for patients  
 
- Access to/provision of the appropriate facilities/skills for advanced vascular and 
neurological assessment such as Doppler assessment for ABPI’s, vascular ultrasound.  
 
- Provision of the appropriate facilities and skills for lower limb mechanics and foot 
pressure assessment. Many rheumatic disorders affect both the architecture and 
function of the foot and lower limb resulting in abnormal gait and increased foot 
pressures. Quantifiable assessment of these will enable monitoring and timely 
intervention. Where available, In-shoe foot pressure assessment will identify the effects 
of orthotic and footwear interventions (Hodge et al 1999, Minns and Craxford 1984) 
 
- The facility for an annual review and assessment of all RA patients. This is so that 
patients who do not have current problems are monitored at least annually in order to 
detect problems early. 
 
- An effective system of Continuing Professional Development, which includes  
 
o The development of advanced clinical skills such as soft tissue and intra-articular 
injection techniques, imaging modalities 
o The training in skills such as lipid and blood pressure monitoring 
o Attendance at regional, national and international rheumatology meetings and 
o conferences (for example, the British Society of Rheumatology Conferences) 
o Support for research (either uni-professional or multi-professional) in collaboration 
with outside agencies (for example, universities, medical schools, and medical 
charities). 
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4. REFERRAL GUIDELINES 
 
It is recommended that all patients with rheumatic diseases, which manifest themselves in 
the foot and ankle should have access to a dedicated and specialist podiatry service (NICE 
2009, Williams and Bowden 2004). The Standards of Care for people with Musculoskeletal 
Foot Health Problems (2008) document states that all patients should be referred within 3 
months of diagnosis, not just those with a problem. 
 
 
 
 
 
 
4.1 Referral Pathway 
 
A pathway of referral should be in place to facilitate patient referrals to the specialist 
podiatrist service by any member of the podiatry team, the multidisciplinary rheumatology 
team, primary care team or private practitioners. 
 
A question about foot problems and foot pain should be included in any assessment by 
consultants and their teams or primary care specialists to facilitate an appropriate and timely 
referral of the patient to the podiatry service. 
 
 
4.2 Foot Screening Pathway 
 
The aim of the Foot Screening Pathway (Appendix 1) and the Primary Assessment/ Annual 
Screening Tool (Appendix 2) is to enable any member of the podiatry team or other 
designated personnel assessing a patient to identify those patients who are at risk from 
ulceration or the development of deformity and to initiate appropriate and timely interventions 
care. It is recommended that private practitioners who manage patients with RA for general 
foot care on a regular basis make links with the specialist podiatry services in order to 
facilitate timely referral of those patients who foot health deteriorates. 
 
Thorough assessment and review are essential in managing patients’ foot health with the aim 
of reducing pain, improving mobility and independence. Further to this, podiatrists aim to 
provide holistic care enabling patients with RA to maximise their potential to fulfil their social 
and occupational roles. 
 
Individual podiatry services will have different clinical arrangements for new and existing 
patients with RA in both primary and secondary services (and private practice) However, an 
initial structured foot assessment and screening must be carried out for all patients with RA 
at the first point of contact with any podiatrist and then referral on to the specialist podiatrist 
if the management needs require specialist intervention or the input from the 
multidisciplinary team. The structured foot assessment should be repeated periodically to 
detect any changes in foot health status. 
 
 
Essential standard  
All patients should be referred for foot health assessment within 3 
months of diagnosis of RA (PRCA 2008) 
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5. PATIENT AND FOOT HEALTH ASSESSMENT  
 
Clinical assessment should be systematic and thorough. The following components of a patient 
assessment / screening process should be carried out as a minimum standard of care for all 
new or existing patients presenting with new foot pathologies (see Appendix 1 and 2) . This 
enables an individual tailored care plan to be produced. It is recommended that all existing 
patient records are updated in line with these standards.  
 
5.1 Essential Requirements for Assessment 
Podiatry referral should be offered to all patients with RA and a Baseline Assessment should 
include:- 
• Full Medical and surgical history (including disease duration). 
• Medication and pain management. 
• General health and systemic factors, examination for signs of extra-articular features of 
disease- nodules, bursa, vasculitis, tendonitis, tenosynovitis. 
• Detailed assessment of foot and lower limb function and structure (both non weight-
bearing and weight-bearing).  
• Feel, look and move the foot assessing the foot position, deformities, range of 
movement and location of painful, tender, swollen sites. 
• Assessment of foot pain using a scale of 0 (no pain) -10 (worst pain imaginable) 
• Assessment of patients’ main presenting problem, the pattern of distribution and 
chronological development of symptoms. The impact of the problem, patients’ 
perceptions/knowledge and expectations also needs to be addressed. 
• Vascular assessment based on clinical signs and patients’ symptoms. Foot pulses 
should be assessed using Doppler ultrasound which provides an objective 
measurement of vascular status. 
• Sensation assessment with 10g monofilament as a minimum. 
• Assessment of nails, skin lesions and tissue viability also noting history of previous 
ulceration. 
• Examination of the patients’ footwear and its suitability for both home and outdoor use 
(Footwear Suitability Scale – Appendix 3). 
• Assess the need for pressure relief and foot orthoses. 
• Assess the need for referral for patients’ requiring a surgical opinion or to other 
members of the MDT such as physiotherapy, occupational therapy or orthotist. 
• Lifestyle and social factors- ability to self care, neglect, smoking, alcohol, occupation 
and activity/mobility. 
• An annual review of foot health should be offered. Patients should be monitored and 
reassessed for changes in foot health and general health status. Allowing further 
outcomes to be predicted and patients’ treatment and management plans to be 
changed accordingly 
 
 
 
 
 
 
Essential Standards 
 
All people with RA and foot problems should have access to a podiatrist for 
assessment and periodic review of their foot health needs. (NICE 2009) 
 
Referral to a Podiatrist is an integral part of the early management of RA patients.  
(SIGN 2000). 
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5.2   ‘Gold Standard’ Requirements for Assessment 
 
In addition to the essential standards it is desirable that the following are also carried 
out: 
• Baseline measurements of foot pain, function and health status using measurement 
tools such as the Foot Function Index (Budiman Mak et al 2006), Leeds Foot Impact 
Scale (Helliwell et al 2005) or the Salford Rheumatoid Arthritis Foot Evaluation Index 
(Walmsley et al 2010).Appendix 4 
• The use of tools such as DAS28 to evaluate disease activity 
• ABPI if further investigation of vascular status is required. 
• Assessment of tendon reflexes where indicated 
• All existing patient records are updated in line with these standards. 
• Direct referral for x-rays / ultrasound / MRI scans for detailed assessment and diagnosis  
 
 
5.3     Musculoskeletal Ultrasound for Foot and Ankle Pathology 
 
Ultrasound imaging is an aid to musculoskeletal assessment and diagnosis (Wakefield, et al 
1999; Backhaus et al 2001; Balint et al 2001). It is painless, harmless (no ionising radiation), is 
readily accessible for use within the clinical environment and is relatively inexpensive. Additional 
advantages over other imaging techniques are that any area of the foot can be scanned rapidly at 
one time-point and treatments such as guided steroid injections can be implemented immediately 
(Bowen 2003). Traditional grey scale ultrasound imaging allows visualisation of synovitis, joint 
capsule rupture, bursitis, tenosynovitis, tendonitis and tendon rupture, joint surface irregularities 
and erosions, osteophytes, loose joint bodies and foreign bodies (Coakley et al 1994; Koski 1998; 
Backhaus, et al 1999; Schmidt et al 2000; Wakefield et al 2000; Grassi, et al 2001; Bowen, et al 
2010). Newer MSUS machines with power Doppler and Colour flow features also allow for 
evaluation of inflammation within the foot structures. (Brown et al 2008). 
 
Specific competencies for ultrasound performed by non radiologists have been rigorously 
developed (Brown et al 2007). The most recently proposed framework for development of 
competencies in MSUS scanning techniques recognises the challenges of training and 
recommends that learning is tailored to areas directly relevant to a clinician’s discrete field of 
practice (Brown et al 2007). 
 
∗ Effusions and impingements of the ankle joints. 
Uses for Musculoskeletal Ultrasound 
∗ Visualisation of synovial hypertrophy, especially within the metatarso-phalangeal joints 
∗ Tenosynovitis of extensor digitorum longus, extensor digitorum brevis, flexor digitorum 
12 
 
longus, flexor digitorum brevis, tibialis anterior, tibialis posterior, peroneus longus and 
peroneus brevis tendons. 
∗ Visualisation of Achilles tendon in its full length - calcification, ruptures and retro-calcaneal 
bursitis can be differentiated. 
∗ Diagnosis of synovitis via Power/Colour flow Doppler, especially within the metatarso-
phalangeal joints. 
∗ Diagnosis of morton’s neuroma. 
∗ Diagnosis of adventitial (within plantar fat pad) and anatomical (intermetatarsal) bursitis. 
∗ Diagnosis of persistent post operative pain. 
∗ Screening of diabetic and rheumatoid patients for high metatarsal pressures. 
∗ Guidance of needle placement for steroid injections 
 
 
6. MANAGEMENT OF FOOT PROBLEMS 
 
6.1 Focus of Management 
Treatment and care should take into account peoples’ needs and preferences. People with RA 
should have the opportunity to make informed decisions about their care and treatment, in 
partnership with their health professionals. 
Good communication between healthcare professionals and patients is essential. It should be 
supported by evidenced-based (where possible) information / care plan tailored to the individual 
person’s needs. Treatment and care and information given should be appropriate to the 
individual and take into account cultural, religious, language needs and be accessible to people 
with physical, sensory or learning disabilities (NICE 2009).  
Following a detailed assessment a management plan will be formulated between the podiatrist 
and the patient. This may involve referring the patient to other members of the rheumatology 
team for advice on interventions such as foot surgery, physiotherapy, specialist footwear  or 
steroid injections.  
Dependent on the presenting problems the podiatrist may offer the following interventions (each 
is then covered in detail), 
• Management of plantar callus  
• Conservative and surgical management of pathological nail conditions 
• Foot orthoses and Footwear (Advise / therapeutic)    
• Management of Foot Ulceration   
• Patient education relating to all issues surrounding foot health    
• Referral for a surgical opinion    
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• Joint injections  or referral to the member of the multidisciplinary team responsible for 
this  
• Referral to other members of the rheumatology team i.e. physiotherapy, occupational 
therapy, specialist nurses, orthotists and consultants 
  
Regardless of the intervention/s, regular review appointments and open access to the 
podiatry service for any developing acute problems 
 
6.2 Management of Plantar Callus  
 
In rheumatoid arthritis (RA) prominent metatarsal heads are subject to excessive shear and 
compressive forces during gait. These stresses stimulate the stratum corneum to produce well 
circumscribed painful skin lesions or callosities. 
This area is poorly researched with only two small trials investigating plantar callus reduction in 
RA.  Stableford at al (2000) demonstrated that reduction of plantar callus with scalpel 
debridement in rheumatoid arthritis reduces forefoot pain (up to 48%) but for a very limited time 
(7 days). Reduction in callus resulted in an increase in forefoot pressures in 10 out of 14 feet. 
This was not statistically significant but indicates that reduction of callus over prominent 
metatarsal heads may lead to tissue damage. This would be of particular concern in patients 
with the following factors 
• Foot deformity 
• Reduced tissue viability (long term steroid therapy, vasculitis, concurrent peripheral 
vascular disease) and/or neuropathy. 
The second study (Davys et al 2005) also demonstrated a reduction in pain in 38 participants 
but concluded that the effect was no greater than sham treatment. Localised pressure or gait 
function was not significantly improved following treatment. The management of plantar 
callus should include the following, 
 
• Patients should be informed about both the cause and management of the callus. 
• Removal of superficial callus over plantar bursae must be avoided altogether. 
• It is recommended that removal of thick callus is carried out cautiously and frequently.  
• If infection is suspected, then overlying callus should be debrided in order to expose the 
underlying infection. In the case of foot ulceration, it is appropriate that surrounding 
callus and necrotic tissue is debrided.  
• Pressure relieving and functional orthoses have been demonstrated in studies to reduce 
forefoot pressures should be provided (Hodge et al 1999, MacSween et al 1999, 
Redmond et al 2000, Woodburn et al 2002(a))  
• Advice about the use of emollients for dry plantar callus should be given.  Patients 
should be encouraged to self manage by applying emollient daily and to use a foot file 
on these areas at least three times a week. 
• Ideally adhesive plantar padding should not be used to provide pressure relief 
especially where there are concerns regarding tissue viability. If localised protection is 
required, a dry dressing held in place with bandage can be used. 
• Footwear advice should be provided so that shoes are deep and wide enough to 
accommodate the patients feet (see section on footwear and orthoses).  
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• Therapeutic footwear should be considered and if appropriate the patient referred to an 
orthotist 
• If the patient has severe pain in the forefoot and/or severely affected mobility, it may be 
appropriate to refer the patient for a surgical opinion 
 
 
 
 
 
 
 
6.3 Conservative and Surgical Management of Pathological Nail Conditions 
 
Onychomychoses 
 
Onychomycosis (OM) is an infection of the nail unit that can be caused by various species of 
dermatophytes, yeasts, molds and even some bacteria.  OM infects between 5 and 13% of the 
population with increasing frequency as patient age increases and there is an increased 
association with immune-compromised hosts (Bodman 2003). Bodman (2003 also identified 
that if OM is left untreated, it can lead to subungual and skin ulceration, in patients with RA. 
 
The most sensitive diagnostic test is histopathological analysis of a nail clip biopsy. A Periodic 
Acid-Schiff stain (PAS) test is commonly used as a quicker and more sensitive diagnostic 
workup than traditional fungal cultures (Arca et al 2004). There are five types of OM: 
• Distal Subungual Onychomycosis (DSO) 
• Superficial White Onychomycosis (SWO) 
• Proximal Subungual Onychomycosis (PSO) 
• Total Dystrophic Onychomycosis(Primary) (TDO) 
• Total Dystrophic Onychomycosis (Secondary)  (TDO) 
 
Treatment of onychomychoses 
 
• Regular Podiatry treatment.  Thorough debridement of all dystrophic and hypertrophic 
nail plates to relieve painful pressure and facilitate topical agent penetration to the nail 
bed.  This also allows the podiatrist to check for subungual ulceration. 
• Topical Therapy.  Topical Lacquers such as Trocyl (Tioconazole), Loceryl (Amorofine) 
and Lamisil (Terbinafine).  These treatments can be effective in the treatment of early 
infections with limited involvement, such as DSO and SWO. Occasional local irritation 
and hypersensitivity reactions can occur, such as mild burning, erythema and itching. 
• BNF (2009) states systemic antifungal treatments are more effective than topical 
treatments and Terbinafine is the drug of choice for OM.  Oral antifungal therapies e.g. 
Sporanox (Itraconazole) and Lamisil (Terbinifine hydrochloride) are frequently used as 
they have a broad spectrum of activity and require a short duration of treatment.  These 
Essential Standard  
Callus should be assessed in relation to symptoms and causative factors before 
debridement is considered. 
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treatments would be recommended for PSO and TDO.  There are many possible contra 
indications which require caution when prescribing.  
o Hepatic and Renal Impairment  
o Risk of exacerbation of Psoriasis 
o Risk of Lupus-erythematosus like effect.  (Autoimmune Disease) 
o Pregnant and nursing mothers. 
o Drug interactions 
 
Patients with known or suspected immunodeficiency need to complete blood counts 
and monitoring as the drug may induce a transient decrease in absolute lymphocyte 
counts which may cause severe neutropenia.  If clinical signs and symptoms are 
suggestive of a secondary infection and full blood count shows a neutrophil count 
<1000 cells/mm treatment should be discontinued.  
 
 
 
 
 
 
 
 
 
 
 
Onychocryptosis 
 
Onychocryptosis (O/C)  is a common problem for which patients seek Podiatry treatment.  The 
nail may puncture the soft tissue and allow bacterial invasion resulting in paronychia and 
infection, often accompanied by hypergranulation tissue. 
 
Treatment of onychocryptosis 
 
In the first instance for mild O/C regular conservative podiatry treatment should be carried out in 
an attempt to resolve the situation. If indicated an appropriate dressing regime and antibiotic 
therapy should be arranged to assist management of localised infection.  If the condition fails to 
resolve or presents as gross O/C with pain, infection and / or hypergranulation tissue, partial or 
total nail avulsion should be considered as first line treatment.  
 
 
 
 
 
 
 
 
Before undertaking nail surgery, a thorough assessment should be carried out (as per local 
requirements) and informed consent obtained.  
Essential Standard  
Fungal infections (of the nail and skin) must be investigated and treated. If left 
untreated they can lead to ulceration and secondary bacterial infection. 
Discussion with the patients GP or consultant is advised before systemic 
treatment is instigated 
Essential Standard  
Consultant advice should be taken on ingrown nails (O/C) if the patient is being 
managed with a biologic therapy and where there are signs of clinical infection 
and or the need for nail surgery 
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It is advised that all patients with RA undergoing nail surgery (regardless of their medical 
management) should have a written agreement by their consultant or GP obtained by the 
podiatrist planning to carry out the procedure.  
The final decision to carry out nail surgery should take place on the day it is planned and 
cancelled if there are any changes in general or foot health or medication that may have 
implications to the procedure or post operative healing. 
 
Prior to any decision regarding nail surgery it may be useful to consider the following: 
• ESR and CRP should be checked prior to surgery to check current disease activity 
• The trauma of a local anaesthetic and nail surgery on a patient with active disease can 
increase the risk of vasculitis progressing to gangrene.  
• Raynauds phenomenon is characterised by an abnormal vasospastic response of the 
digital arterioles to emotional or temperature changes. Nail surgery should never be 
attempted during a vasospasm as the local anaesthetic stays in place longer acting as a 
partial tourniquet. It may be advisable to carry out the surgery in the warmer summer 
months 
• Prostocycline infusion may be necessary to maximise the circulation to the area  
• Patients taking immuno-suppressive drugs may require prophylactic antibiotics and 
possibly suspension of their therapy. Consultant advice should be sort as necessary. 
• The patient’s medication may need to be increased in preparation of the trauma to 
the body during the surgical procedure. 
• The optimum time for surgery may be after the patient has had a disease flare up 
whereby close monitoring and altered medication has resulted in disease stability. 
• The use of a tourniquet may not be advised for the whole time during surgery. Some 
consultants prefer that tourniquets are only used during phenolisation of the nail 
matrix. 
 
This guidance is not intended to replace any local trust nail surgery policy or protocol which 
should be followed accordingly. 
 
 
 
6.4 Foot Orthoses and Footwear  
The benefits of foot orthoses (insoles) and footwear have been recognised and 
recommended “Functional insoles and therapeutic footwear should be available for all 
people with RA if indicated” NICE (2009). For the purposes of clarity foot orthoses and 
footwear options will be discussed separately. However, the practitioner should always 
consider them together in relation to footwear suitability, choice of foot orthoses and the 
potential mechanical effect of the footwear on not just the foot but the orthoses as well. 
Foot orthoses 
Foot orthoses are provided to two main groups of patients with RA; those with foot problems 
associated with early disease and those with more established foot problems. The use of 
appropriate footwear (Fransen and Edmonds 1997, Williams et al 2007) in conjunction with 
foot orthoses has been recognised as minimising the pain and disability associated with RA 
(Hodge 1999, MacSween 1999) when there is established foot deformity. The choice of foot 
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orthoses in relation to design and function is dependent on the amount of motion in the joint 
of the foot. This factor is not dependent on disease duration as some patients with early 
disease have limited motion and some with longer disease duration have good range of 
motion within the joints of the foot. 
It is demonstrated that foot orthoses not only achieve pain reduction in the early RA foot but 
have a sustained effect on the foot structure and hence achieve stability of the joints of the foot 
and improve the patient’s mobility (Woodburn at al 2002(a)). 
Therefore, there is the potential to prevent major functional and structural foot problems by 
providing foot orthoses early on in the disease process if joint mobility is still good. However, 
as foot changes have the potential to occur within 2 yrs of disease onset (Turner et al 2006) 
it is essential that patients are referred for assessment of foot function as early as possible 
following diagnosis. 
 
 
 
 
 
Once the structural problems are established and joint mobility is reduced, management 
consists of reducing symptoms of pain and resultant mobility problems. Further to this, 
redistributing foot pressures may contribute to the prevention of tissue breakdown and 
ulceration over high pressure areas of the foot. 
 
There is a broad range of devices that employ a variety of different approaches to modify 
foot and lower limb structure and function with general consensus within services providing 
them that foot orthoses include these main groups: 
• Simple cushioning insoles 
• Insoles to which additional padding/additions can be applied  
• Contoured insoles intended to change the function of leg and foot joints, either: 
o Custom made to a cast of the patient’s foot 
o Supplied off the shelf  +/- adaptations  
 
However, the boundaries between the modes of action of the types are not always exact and 
an individual device may include elements of more than one type or mode of action.  
However, Clark et al (2006) concluded that foot orthoses; 
• reduce pain and improve functional ability 
Essential Standard  
Patients with established foot deformity should be assessed for accommodative 
foot orthoses and footwear advice/ specialist footwear 
Essential Standard 
Patient with a diagnosis of RA should be assessed as soon as possible 
following diagnosis for structural problems with the lower limb and foot. 
 
All patients with RA and foot pain should be considered for foot orthoses and 
/or footwear advice, irrespective of disease duration. 
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• Both hard and soft foot orthoses have the potential to reduce forefoot pain 
• Hard foot orthoses have the potential to reduce rearfoot pain in patients with early RA 
• Hard foot orthoses have the potential to reduce hallux abducto valgus 
 
There is only anecdotal evidence for the use of simple cushioning insoles. Two small studies 
indicate that prefabricated metatarsal padding (dome and bar shapes metatarsal pads) 
reduces mean peak plantar foot pressure by up to 21% with bars and 12% with domes 
(Jackson et al 2004) and both equally (Hodge et al 1999) 
Hard Contoured foot orthoses are provided in order to improve the function of the foot and/or 
lower limb. This assumes that there is some mobility in the joints of the foot in order to improve 
function and realign the bony architecture. They are particularly useful for use in patients with 
early diagnosis of RA. In this case there is an attempt to not only reduce pain but to maintain 
good foot function and hence structure whilst the foot is vulnerable to deformity due to the 
combination of the inflammatory process and abnormal mechanics.  
Customised accommodative orthoses (total contact orthoses) are designed so that the material 
follows closely the contours of the underside of the foot. The purpose is to redistribute the 
pressures applied to the foot by standing and walking more evenly. This is particularly useful 
where there are areas of increased pressure, for example, under the metatarsal heads. In this 
instance the pressure is shifted to areas of the foot that do not normally bear weight such as the 
arch area (Li et al 2000). They are particularly used where there is limited or no joint mobility 
such as in the established RA foot and where tissue viability is poor. These orthoses are often 
made from materials that also provide a cushioning effect, such as softer EVA or with additional 
foam linings. 
 
 
 
 
 
 
Footwear 
The choice of orthoses is governed by the suitability of the patient’s footwear, which may not 
accommodate the ideal foot orthoses for their particular problem.  
All footwear is in itself capable of modifying the structure and function of the body and 
therefore falls clearly within the definition of orthoses and may the only thing that needs 
changing to solve functional problems. 
Inappropriate footwear can be both a major contributing factor to foot impairment. However, 
when it is right it has the potential to alleviate pain and increase mobility and independence 
(with or without foot orthoses). 
Essential Standards 
Functional foot orthoses should be provided where the tarsal joints are 
unaffected. 
 
Accommodative / cushioning orthoses should be provided for those patients 
with structural foot deformity, painful symptoms and activity restriction 
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Footwear can be sub divided into three main groups: 
• Standard retail footwear 
• Niche retail including comfort footwear as well as extra depth, extra width and odd-size 
suppliers. 
• Specialist therapeutic footwear  
o standard or ‘stock’ footwear 
o modular footwear based on a stock base and customisable to individual needs  
o made to measure or bespoke footwear 
 
Standard Retail footwear 
There are now many manufacturers of retail footwear that are both appropriate for the foot 
health of our patients The features of retail footwear that makes them ideal for the RA  foot 
would be -  
• Stable heel – broad enough for stability or elongated / flared to increase this effect 
further 
• Extended heel counter 
• Padded topline – to reduce irritation to the retro-calcaneal area and the infra-malleolar 
areas 
• No prominent internal seams 
• Winged toe puff 
• Increased toe spring or rocker sole – to reduce forefoot plantar pressures 
• Low laced – for ease of access 
(Williams 2006, Sherrington and Menz 2003) 
The suitability of retail footwear can be assessed using the Footwear suitability tool (Nancarrow 
1999) see Appendix 3 
 
 
 
In early disease many patients experience forefoot pain and changes to the shape of their 
foot. Many patients recall that they had to increase their shoe size to accommodate a wider 
forefoot. Specialist footwear manufacturers can be very helpful in offering advice and 
providing wider-fitting shoes. The British Footwear Association (http://www.britfoot.com/) 
provides detailed information about companies that make up the British footwear industry 
and consumer information about hard-to-find footwear suitable for all foot sizes and shapes 
 
Specialist therapeutic footwear   
 
Two systematic reviews (Egan et al  2003  and Farrow et al  2005)    indicate that specialist 
footwear is likely to be beneficial in patients with RA. Two RCT’s (Fransen and Edmonds 1997 
and Williams et al 2007) indicate that this footwear contributes to the reduction in pain and 
Essential Standard  
Footwear assessment and advice should be given to all patients. 
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increased mobility in patients with RA although the effect is improved when combined with 
orthoses (Chalmers et al 2000) 
 
It is generally considered that the following patients could be considered for referral for 
specialist footwear for the following reasons: 
 
• Failing to obtain retail footwear to fit the dimensions of the foot (including asymmetry) 
• Pressure symptoms such as skin lesions/sore areas on the feet 
• Increasing foot pain due to pressure from existing footwear 
• Excessive footwear ‘wear’ indicating that patients need more stability from increased 
surface area of the plantar aspect of the footwear and increased rearfoot control from 
the heel counter. 
• History of foot ulceration where footwear has been a contributory factor. 
 
It has been found that patients considered that it was important to receive information at the 
point of referral so that they can make considered choices as to whether to be referred or not 
(Williams et al 2008). Without some knowledge of what is available the opportunity to 
engage the patient in the decision making at this stage is lost and may be one of the reasons 
patient expectations are not met. The option of referral for a surgical opinion should be 
offered as an alternative to referral for footwear.  
Stock footwear is specialist footwear which is available in a variety of styles and fittings, for 
example extra deep, and/ or extra wide and is generally suitable for mild to moderate deformity. 
This footwear is generally supplied with 3x3mm removable liners that provide the option for 
being replaced with orthotic devices. Stock footwear an modified and then it is termed 
‘modular’. Bespoke footwear is an option when there is major deformity such as advanced 
rheumatoid arthritis deformity or if there is a huge difference in symmetry, or if the foot 
dimensions are outside the measurements for stock footwear.  
 
 
 
 
 
 
 
 
 
6.5 Management of Foot Ulceration 
 
It is likely that ulcers in Rheumatoid Arthritis (RA) are multifactorial in origin and these factors 
may contribute to the poor rates of healing. 
Arterial disease as a factor has a higher incidence and prevalence in RA (McEntegart et al 
2001). Traumatic ulceration, secondary to foot or ankle deformities may be made worse by 
poorly fitting shoes and/or sensory neuropathy which is associated with RA. 
Immunosuppressive therapy (especially corticosteroids), or poor nutrition (common in long 
standing RA), may also contribute. 
Essential standards –   
Patients who are struggling with retail footwear due to deformity should be offered the 
option of being referred for therapeutic footwear. They should be informed of the 
potential benefits and limitations of this footwear (in respect of cosmesis). 
 
Referral for surgical opinion should be offered as an alternative to referral for therapeutic 
footwear 
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The role of cutaneous vasculitis in the aetiology of ulceration can be difficult to determine in 
the feet. It is important to look for other clinical evidence of systemic vasculitis such as nail-
bed infarcts, splinter haemorrhages, mononeuritis multiplex. Systemic rheumatoid vasculitis 
usually occurs in longstanding RA patients. 
 
The aim of ulcer management is to create the best environment for healing to occur and to 
minimise adverse factors that delay the healing process and patient comfort.  
The factors are:- 
• Existing disease/medication 
• Poor nutrition  
• Poor patient compliance with treatments and advice  
• Inappropriate management of the ulcer. 
 
 
 
 
 
The foot assessment should be structured and detailed including vascular, neurological and 
foot structure/function assessments. Identification of risk factors such as poor nutrition, 
smoking and contributory factors such as ill-fitting footwear is vital as these are potentially 
modifiable. Ideally ESR, platelet counts, blood glucose and FBC should be checked and X-
rays may also prove valuable in the management of foot ulceration. 
 
Aims of Treatment: 
• Keep free from infection / relieve pain 
• Prevent deterioration / improve foot function 
• Promote healing / establish wound closure 
• Prevent reoccurrence / maintain tissue viability 
 
Treatment 
• Assessment of the ulcer i.e. type, location, duration, size. 
• Debridement of the ulcer if necessary 
• Investigations  as appropriate e.g. x-ray, wound swab if clinical infection is suspected. 
• Management of  any  infection according to local policies 
• Antibiotics via GP/consultant if required 
• Suitable dressings according to type of ulcer – see local Trust Protocols. 
• Pressure relief and/or provision of orthoses if indicated 
• Footwear assessment with appropriate action including advice, adaptation and referral 
to orthotist if required. 
• Referral to consultant/GP/multi-disciplinary team member. 
• Patient education / involvement in the management of their condition. 
• Advise consultant / rheumatology team of ulcer / infection, particularly if the patient is 
managed with a biologic therapy 
 
 
 
Essential Standard  
Optimum ulcer management can only be achieved by a holistic and integrated 
multi-disciplinary team approach 
Essential Standard  
Contact the patient’s consultant / rheumatology nurse IMMEDIATELY if the 
patient is being managed with Biologic therapy and develops an ulcer and/or 
infection. 
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6.6 Patient Education Related to Foot Health 
 
Patient Education (P.E) can be defined as: a set of planned educational activities designed to 
improve patients’ health behaviours, health status and long term outcomes (Hill, 1997). Patient 
education is considered to be an integral component in the armoury of R.A. management 
strategies, to support and facilitate self-management of the disease (ARMA, 2004). Further to 
this research has shown that individuals who are actively involved their own disease 
management have better outcomes, improved self-efficacy, less pain and reduced incidence of 
depression (Lorig et al, 2005; Kjeken et al, 2006). 
 
The Standards of Care for People with Musculoskeletal Foot-health Problems (PRCA, 2008) 
recommend specifically that patient-centred education should be provided to enable patients to 
make informed choices about their foot care, and the role of the podiatrist as a vital member of 
the Multidisciplinary team for the management of R.A. has been reinforced (NICE 2009). 
 
Podiatrists have a prominent role to play in symptom relief and improving overall quality of life 
through specific interventions, foot health advice and education (PRCA 2008), also in certain 
health behaviours and other aspects of the condition. There is a lack of podiatry-based 
research regarding the provision or effectiveness of podiatry focused P.E. related to R.A. foot 
problems. However, there is a large body of evidence that supports the effectiveness of P.E. for 
patients with R.A. that is delivered via a staged approach over the lifetime of the patient, with 
the content and timing of education provision being driven by the needs of the individual 
(Donovan et al, 1989; cited in Hill, 1997; Barlow and Wright, 1998; Barlow et al 2002; 
Hammond 2003; Waxman et al 2003; Hennell et al (2004); Schrieber & Colley, 2004; Fautrel et 
al 2005; Riemsma et al 2005; Luqmani et al 2006; Makelainen et al 2007; Koehn and Esdaile , 
2008). 
 
Using the recommendations and findings from the literature above as a guide, together with the 
PRCA (2008) Foot Health standards, Podiatrists can embed the following key points into the 
development of their Foot Health P.E. provision for individuals with R.A. 
 
Education should be encouraged throughout the patients’ medical care with each consultation 
becoming an opportunity for P.E and be based on an educational-behavioural approach. The 
content of P.E. should be individualized according to the patients’ needs/wishes at the point of 
contact and should reflect the fluctuating nature of the disease.  
 
It should aim to include: 
• Disease specific information regarding; the causes & course of the disease and disease 
management. 
• Details regarding access to patient support groups 
• Advice regarding lifestyle choices (weight management, smoking cessation). 
• Advice regarding retail/therapeutic footwear/foot orthoses. 
• Maintenance of foot hygiene. 
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• Aspects of self-care (including safe & unsafe practices. 
• Information regarding changes in foot health that should prompt further investigation. 
• Access to service / providers of podiatry care 
 
Simple information giving only has short-term, limited effects upon health behaviour, but should 
be used within a staged approach throughout the course of the disease. An opportune time for 
general information giving is early in the diagnosis, based upon the patients’ own knowledge 
requirements. To maintain the potential effects of P.E over the lifetime of the patient, 
educational ‘booster’ sessions may be required. 
 
 
 
 
 
 
 
 
 
6.7 Foot Surgery 
 
Whilst it is recognised that advances in the medical management of RA with biologic therapies 
has seen a reduction  in the requirement for orthopaedic surgery, many patients with the 
disease will go on to develop problems with their feet and ankles that may require a surgical 
opinion (NICE guidelines 2009). 
 
Reasons for surgical referral may include: 
 
Persistent pain, stiffness, synovitis in the foot or ankle joints, tenosynovitis or tendon ruptures, 
foot deformities causing restriction in mobility due to pain, or recurrent ulceration, Osteomyelitis 
/ septic arthritis. It is generally accepted that referrals for surgical opinion should be considered 
for patients with RA when optimum conservative management has failed to bring their 
symptoms to an acceptable level. However, one should always be aware of potential 
exceptions such as earlier synovectomy in severe disease, to prevent rapid joint destruction 
(Harris et al 2007) 
 
 
 
 
Conservative management (prior to surgical referral) should consider accommodative footwear, 
orthoses, steroid injections and a comprehensive individualised package of podiatry care  
 
Essential standard 
 
Red Flags requiring urgent referral include  
• Tendon rupture e.g. Tibialis posterior, Achilles Tendon 
• Septic arthritis 
• Suspicion of cancer 
 
 
Essential Standard  
Patient education should include foot health self management advice and if 
necessary demonstration, explanation of foot problems and their impact on the 
individual, information on general disease management and sign posting for 
future foot health needs 
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Coughlin (1999) describes the main intended benefits of orthopaedic surgery to be pain relief, 
prevention of deformity, correction of deformity, preservation of function and/or restoration of 
function. The overall aim is to maintain independent mobility thus improving quality of life. 
However, the aims of surgery need to be counterbalanced against the potential risks of: 
• Infection   
• Recurrence of deformity 
• Non – union 
• Neuro – vascular damage 
 
For further information please see - http://www.blackburnfeet.org.uk 
 
 
 
6.8 Steroid Injection Therapy  
 
The structures of the foot and ankle in RA are particularly susceptible to inflammation and are 
amenable to both diagnostic and therapeutic injection of steroid. This therapy allows for specific 
targeting of localised joints which may be symptomatic even though the general disease 
process is controlled by oral medications. Therefore, the main indication for use of therapeutic 
injection therapy is for active joint inflammation and pain relief but only in the absence of sepsis. 
 
 
 
 
 
 
Hay et al (1999) found that the close proximity of joints in the foot can make accurate clinical 
localisation difficult. Therefore, the use of injections can also be diagnostic if local anaesthetic is 
used allowing for identification of problematic structures (Helliwell et al 2007).  
 
Administering steroids via the intra articular or localised soft tissue approaches has advantages 
over oral use of steroids. Typical systemic side effects seen with steroids are reduced and 
improvement can be rapid. Ward and Williams (2008) found improvement following 
corticosteroid injection up to and including 6 months post injection. 
 
Common sites for injection include the ankle joint, subtalar joint, first metatarso-phalangeal 
joint, interphalangeal joints, the plantar fascia, interdigital spaces, the tarsal tunnel, retro-
calcaneal bursae and tendon sheaths of the peroneal and posterior tibial tendons. 
 
Essential standard 
Consider steroid injection therapy for targeting  localised, inflamed 
joints when the general disease is controlled (but only in the 
absence of sepsis). 
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Conclusive evidence for the type of steroid used (long or short acting), +/- local anaesthetic is 
lacking and depends on individual consultant choices, local policies and availability. Commonly 
used steroid preparations include Methylprednisolone 10-60mg, Triamcinolone 10-40mg and 
Hydrocortisone 25-50mg depending on site of injection. Local anaesthetics used include 
Lidocane 1%, 2% or Bupivacaine 0.25%, 0.5%. 
 
The benefit gained from injection therapy depends on a number of factors:  
 
• Correct diagnosis of the presenting complaint  
• Appropriateness of injection therapy as treatment option 
• Degree of inflammation 
• Accurate placement of the injection  
• Type of steroid used  
• The amount of rest following the injection 
• Correction of  any structural deformity using orthoses  
 
All these factors contribute to both the benefit and duration of benefit from injection therapy. 
Jones et al (1993) found that clinical response was closely associated with accuracy of injection 
placement. In the foot, accurate placement is sometimes difficult and often injections are guided 
using x-ray screening or ultrasound (U/S)(Appendix 5) . Without guidance, accuracy of 
placement depends purely on the skill of the practitioner. Using x-ray guidance often leads to 
delay in performing the injection and exposes the patient to radiation. U/S guidance is seen as 
the way forward and is likely to become more common as clinicians are trained in the modality 
and the technology becomes cheaper and more readily available (Brown et al 2004). 
 
 
 
 
 
 
 
 
Potential Risks 
 
As with any invasive procedure there are potential risks, which the referring practitioner needs 
to be aware of and the administering practitioner needs to consider before injection is carried 
out and discussed with the patient before informed consent is obtained. 
There is believed to be a higher risk of post injection infection associated with injections in the 
foot and ankle (Dixon and Graber 1981). However, anecdotally, this risk is reported to be low if 
Essential standard 
Injection therapy should be seen as an adjunct to conventional podiatric 
management in combination with attempts to correct any structural 
deformity using orthoses (Helliwell et al 2007) 
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good aseptic techniques are adopted for any joint or soft tissue injection procedure. Soft tissue 
rupture, especially related to injections of the plantar fascia is also more likely following steroid 
injection (Beales et al 1999, Furey 1975).  
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Foot Screening Pathway for People with RA  
Does the patient complain of foot symptoms?
YES NOFOOT HEALTH EDUCATION ANNUAL REVIEW WITH PODIATRIST
FOOT HEALTH  ASSESSMENT
SKIN
 Ulceration (NB 
cellulitis may be 
minimal – 
indicator of 
infection may be 
pain) 
Requirement for 
antibiotics, 
radiographs
NB Patients on 
biologic therapy 
require urgent 
consultant 
advice if feet 
ulcerate  
Evidence of 
fungal infection
(diagnosed from 
mycology results
SYMPTOMS 
ASSOCIATED 
WITH RA
Disease 
flare.
Generally 
unwell
Weight loss
Fatigue
Signs of 
depression
VASCULAR
Claudication
Rest pain
Vasculitis
Absent pulses 
(with hand 
held Doppler)
NEUROLOGICAL
Sensory loss
Nerve 
entrapment/
compression 
FOOT 
STRUCTURE
Pain and /
swelling 
associated 
with joints/
tendons
Inability to fit 
into retail 
shoes
Evidence of 
pressure 
related 
lesions such 
as callus
FOOT 
FUNCTION 
AND GAIT
Excessive 
pronation
Lack of 
stability
Falls
Poor 
muscle 
strength
Poor 
posture
Reduced 
range of 
motion 
Increasing 
stiffness
LIFESTYLE
Unhealthy 
lifestyle 
habits e.g. 
smoking
Poor diet
Weight loss
ACTIVITIES 
OF DAILY 
LIVING
Increasing 
difficulty 
with 
everyday 
tasks
Difficulty 
coping with 
fatigue
NAILS
Evidence of 
bacterial 
infection (need 
for antibiotics 
and/or advise  
if patient is on 
biologic 
therapy)
Need for nail 
surgery
Evidence of 
fungal 
infection
(diagnosed 
from mycology 
results
RHEUMATOLOGY 
SPECIALIST NURSE
RHEUMATOLOGIST
SPECIALIST PODIATRIST
ORTHOTIST
PHYSIOTHERAPIST OCCUPATIONAL 
THERAPIST 
DIETICIAN
SMOKING 
CESSATION
SURGICAL OPINION
Appendix 1
NB   IN THE ABSENCE OF A SPECIALIST PODIATRIST -
• ADVISE SHOULD BE OBTAINED FROM THE PATIENTS CONSULTANT AS DENOTED BY A RED LINE
• ADVISE SHOULD BE OBTAINED FROM AN ORTHOTIST AS DENOTED BY A BLUE LINE
• BLACK LINES DENOTE DIRECT REFERRAL
• GREEN LINES DENOTE MULTIDISCIPLINARY WORKING BETWEEN THE CORE RHEUMATOLOGY MULTIDISCIPLINARY TEAM 
PAIN MANAGEMENT TEAM
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                                  Example of Primary Assessment / Annual Screening Tool 
 
Name:         NHS No:   
Address:        Unit No:    
D.O.B.          
GP:         Consultant:   
Diagnosis:        Duration:   
 
Relevant Medical History:        _______ 
Allergies:            
 
1. Medication: NSAIDS:          
DMARDS:          
STEROIDS:          
BIOLOGIC:          
OTHER:          
 
2. Vascular Assessment:   Right      Left 
Palpation DP  palpable / non palpable   palpable / non palpable 
PT  palpable / non palpable   palpable / non palpable 
Doppler Assessment: 
  DP            
  PT            
Intermittent Claudication:  yes   no   yes         no 
Rest Pain:       yes         no  yes   no   
 
Other relevant information          
 
3. Neurological Assessment:  Right      Left 
10g Monofilament:  normal / abnormal    normal / abnormal 
Symptoms: sharp pain burning         dull ache     numb           tingling        other  
 
4. Foot Structure Assessment: 
Previous foot surgery / injury:          
 
Extra articular features: 
  N/A 
  Bursae sites           
  Nodule sites           
  Subluxed met heads          
Foot position:            
             
 
 
Range of joint movement - NWB:  Right      Left 
Ankle – knee extended      flexible / reduced / rigid   flexible / reduced / rigid 
Ankle – knee flexed    flexible / reduced / rigid   flexible / reduced / rigid 
Subtalar     flexible / reduced / rigid   flexible / reduced / rigid 
Midtarsal     flexible / reduced / rigid   flexible / reduced / rigid 
1st Ray      flexible / reduced / rigid   flexible / reduced / rigid 
HAV stage           1 / 2 / 3 / 4 / 5          1 / 2 / 3 / 4 / 5 
Lesser toe involvement              2 / 3 / 4 / 5            2 / 3 / 4 / 5  
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5. Nail / skin problems 
Nail pathology            
Skin pathology            
Callus sites             
History of ulceration  yes     no    site       
Current ulcer  yes     no  site       
 
Cause    arterial / vasculitis / small vessel disease / pressure 
Treatment details            
             
 
6. Current pressure relief / orthotic management 
Type:  simple  insole         pre-mould   functional  TCI 
   NA 
   
Footwear:  retail  stock  modular  bespoke  
Appropriate yes / no 
Uses footwear sufficiently to benefit foot health  yes / no 
If no why?  Uncomfortable      appearance     weight other 
 
7. Mobility:             
 
8. Social factors:            
 
9. Presenting complaint:           
 
 
10. Any other relevant information (inc any treatment given): 
   
                 
 
 
11. Plan / Action / Collaboration: 
Routine podiatry treatment    X-ray / MRI / US  
 
Annual recall / self referral    Bloods  
 
Wound care management     Injection clinic 
 
Orthotic intervention      Education 
 
Consultant Rheumatologist    Orthopaedic opinion 
 
Rheumatology Nurse    Vascular investigation 
 
MDT. Specify..........................   Orthotist / Footwear 
 
Other             
 
 
Clinician’s Signature:         Date:    
 
 
 
 
 
 
36 
 
 
 
 
                                      Footwear Suitability Scale (Nancarrow 1999) 
 
1. Is the heel of 
your shoe less than 
2.5cm (1”)? 
As the height of your heel increases the pressure under the ball of 
your foot becomes greater. Increased pressure can lead to callus 
and ulceration 
 
2. Does the shoe 
have laces, buckles 
or elastic to hold it 
onto your foot? 
If you wear slip on shoes with no restraining mechanism, your toes 
must curl up to hold the shoes on. This can cause the tops of your 
toes to rub on your shoes leading to corns and calluses. Secondly, 
the muscles in your feet do not function as they should to help you 
walk, instead they are being used less efficiently to hold your shoes 
on 
 
3. Do you have 
1cm (approx thumb 
nail length of space 
between your 
longest toe and the 
end of your shoe 
when standing?  
This is the best guide for the length of the shoe, as different 
manufacturers create shoes which are different sizes. Your toes 
should not touch the end of the shoe as this is likely to cause injury 
to the toes and place pressure on the toe nails 
 
4. Do your shoes 
have a well padded 
sole? 
Shoes should have supportive, but cushioned sole to absorb any 
shock and reduce pressure under the feet 
 
. Are your shoes 
made from material 
which breathes? 
A warm, moist environment can harbour organisms such as those 
which cause fungal infections 
 
6. Do your shoes 
protect your feet 
from injury? 
The main function of footwear is protection from the environment. 
Ensure your shoes are able to prevent entry of foreign objects 
which can injure the foot. If you have diabetes a closed toe is 
essential to prevent injury to the foot.  
 
7. Are your shoes 
the same shape as 
your feet? 
Many shoes have pointed toes and cause friction over the tops of 
the toes which can lead to corns, callus and ulceration. If you can 
see the outline of your toes imprinted on your shoes, then the shoe 
is probably the wrong shape for your foot 
 
8. Is the heel 
counter of your 
shoe firm? 
Hold the sides of the heel of your shoe between the thumb and 
forefinger and try to push them together. If the heel compresses, it 
is too soft to give your foot support. The heel counter provides 
much of the support of the shoe and must be firm to press 
 
If you have not put a tick in every box, your footwear is probably not protecting and 
supporting your foot as it should be 
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APPENDIX 4 
 
The Salford Rheumatoid Arthritis Foot Evaluation Instrument is a Patient reported Outcome 
Measure that can be used in clinical practice to evaluate the impact of foot problems on the 
lives of people with RA. This enables you as a clinician to evaluate your interventions and 
monitor the foot health of your patients. Please copy this and use in your clinical practice. This 
Instrument was developed by Steven Walmsley who has engaged with patients and clinicians 
in its development – if you require any further information please contact Steven via the email 
below.  
It would be useful to collate information about patient’s foot health before and after interventions 
with the University of Salford as a central ‘hub’ for this activity. If you are interested in 
collaborating in this initiative please contact Dr Anita Williams a.e.williams1@salford.ac.uk  
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